There’s a psychedelic revolution on the horizon that could change mental health treatment. Biotech revolution on horizon could change mental health treatment

There’s a psychedelic revolution on the horizon that could change mental health treatment.

Many doctors are calling it a breakthrough as the world’s mental health crisis reaches a peak. There hasn’t been much in terms of innovation to treat mental disorders in decades — until now. 

MDMA is the latest illegal drug clearing hurdles for widespread medicinal use. A recent clinical trial found the substance, also known as “molly” or “ecstasy,” is effective for treating Post-traumatic Stress Disorder (PTSD). The drug paired with talk therapy is showing success with few minor side effects. 

Before more people can try it, legalization would need to happen. There’s also a big push to clear the way for other psychedelics like psilocybin, the substance in “magic mushrooms.”

Read More

MJ Shareholders avatar

MJ Shareholders

MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers

( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )